Capital Markets Day took place 3 March 2022 (9.00 am – 5.00 pm CET)

Watch the recorded presentations: Capital Markets Day 2022 (evenzu.com).

Download all presentations from the day collected: Novo Nordisk Capital Markets Day 2022 (pdf). You can also get the individual presentations under each agenda item below.

 

Open presentation (pdf)

Watch presentation

Presenter:
Lars Fruergaard Jørgensen, Novo Nordisk President and CEO

Open presentation (pdf)

Watch presentation

Presenter:
Marcus Schindler, CSO and EVP of Research & Early Development

Open presentation (pdf)

Watch presentation

Presenters: 
Camilla Sylvest, EVP Commercial Strategy and Corporate Affairs
Henrik Wulff, EVP Product Supply, Quality & IT
Monique Carter, EVP People & Organisation
Karsten Munk Knudsen, EVP and CFO


Please note that the calculation for the list and net price indexes have been updated on slide 11 in presentation. For insulins, the list and net prices indexes have been updated across the years, amounting to index 116 and 40 respectively in 2021. For full portfolio, the respective numbers in 2021 are index 124 for the list price and 53 for the net price.

Open presentation (pdf)

Watch presentation

Presenters: 
Camilla Sylvest, EVP Commercial Strategy and Corporate Affairs
Doug Langa, EVP North America
Mike Doustdar, EVP International Operations
Martin Holst Lange, EVP Development

Open presentation (pdf)

Watch presentation

Presenters:
Camilla Sylvest, EVP Commercial Strategy and Corporate Affairs
Henrik Wulff, EVP Product Supply, Quality & IT
Doug Langa, EVP North America
Mike Doustdar, EVP International Operations
Martin Holst Lange, EVP Development

Open presentation (pdf)

Watch presentation

Presenters:
Ludovic Helfgott, EVP Rare disease
Martin Holst Lange, EVP Development

Open presentation (pdf)

Watch presentation

Presenters & panel:
Ludovic Helfgott, EVP Rare disease
Martin Holst Lange, EVP Development
Camilla Sylvest, EVP Commercial Strategy and Corporate Affairs
Karsten Munk Knudsen, EVP and CFO

Open presentation (pdf)

Watch presentation

Format: Break-out session

Presenters:
Marcus Schindler, CSO and EVP of Research & Early Developement
Karin Conde-Knape, SVP Global drug discovery
Lars Fogh Iversen, SVP Global research technologies

Open presentation (pdf)

Watch presentation

Format: Break-out session

Presenters:
Frederik Kier, SVP Region North West Europe
Andrzej Popkowski, SVP Region SEEMEA

Open presentation (pdf)

Watch presentation

Format: Break-out session

Presenters:
Martin Holst Lange, EVP Development
Camilla Sylvest, EVP Commercial Strategy and Corporate Affairs

Open presentation (pdf)

Watch presentation

Presenters:
Mike Doustdar and EVP International Operations
Doug Langa, EVP North America

Open presentation (pdf)

Watch presentation

Presenters:
Henrik Wulff, EVP Product Supply, Quality & IT
Karsten Munk Knudsen, EVP and CFO

Panel Q&A

Watch panel Q&A
 

Closing

Open presentation

Watch presentation

Presenter: Lars Fruergaard Jørgensen, Novo Nordisk President and CEO

Investors

Share price

{{priceData.date}} {{priceData.time}}

{{priceData.currentPrice}} {{priceData.currency}}
Go to stock watch {{priceData.change}} {{priceData.currency}}

Annual Report

Cover page of the Novo Nordisk Annual Report 2021

Annual Report 2021

Download Annual Report